Top

The International Journal of Cardiovascular Imaging

Published in:

Open Access 01-03-2020 | Rheumatoid Arthritis | Original Paper

Cardiovascular MRI evidence of reduced systolic function and reduced LV mass in rheumatoid arthritis: impact of disease phenotype

Authors: L. A. Bissell, B. Erhayiem, E. M. A. Hensor, G. Fent, A. Burska, A. K. McDiarmid, P. P. Swoboda, H. Donica, S. Plein, M. H. Buch, J. P. Greenwood, J. Andrews

Published in: The International Journal of Cardiovascular Imaging | Issue 3/2020

Abstract

The accelerated risk of cardiovascular disease (CVD) in Rheumatoid Arthritis (RA) requires further study of the underlying pathophysiology and determination of the at-risk RA phenotype. Our objectives were to describe the cardiac structure and function and arterial stiffness, and association with disease phenotype in patients with established) RA, in comparison to healthy controls, as measured by cardiovascular magnetic resonance imaging (CMR). 76 patients with established RA and no history of CVD/diabetes mellitus were assessed for RA and cardiovascular profile and underwent a non-contrast 3T-CMR, and compared to 26 healthy controls. A univariable analysis and multivariable linear regression model determined associations between baseline variables and CMR-measures. Ten-year cardiovascular risk scores were increased in RA compared with controls. Adjusting for age, sex and traditional cardiovascular risk factors, patients with RA had reduced left ventricular ejection fraction (mean difference − 2.86% (− 5.17, − 0.55) p = 0.016), reduced absolute values of mid systolic strain rate (p < 0.001) and lower late/active diastolic strain rate (p < 0.001) compared to controls. There was evidence of reduced LV mass index (LVMI) (− 4.56 g/m² (− 8.92, − 0.20), p = 0.041). CMR-measures predominantly associated with traditional cardiovascular risk factors; male sex and systolic blood pressure independently with increasing LVMI. Patients with established RA and no history of CVD have evidence of reduced LV systolic function and LVMI after adjustment for traditional cardiovascular risk factors; the latter suggesting cardiac pathology other than atherosclerosis in RA. Traditional cardiovascular risk factors, rather than RA disease phenotype, appear to be key determinants of subclinical CVD in RA potentially warranting more effective cardiovascular risk reduction programs.

Innala L, Moller B, Ljung L, Magnusson S, Smedby T et al (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a 5 year prospective study. Arthritis Res Ther 13(4):R131CrossRefPubMedPubMedCentral

Agca R, Heslinga SC (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28. https://doi.org/10.1136/annrheumdis-2016-209775 CrossRefPubMed

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J et al (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460. https://doi.org/10.1016/S0140-6736(11)61335-4 CrossRefPubMedPubMedCentral

Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y et al (2010) Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 12(5):R171CrossRefPubMedPubMedCentral

Kobayashi Y, Isamu Y, Hirano M, Kobayashi H (2012) Detection of left ventricular regional dysfunction using strain analysis by feature tracking of Cine MRI in rheumatoid arthritis patients without cardiac symptoms. J Cardiovasc Magn Reson 14(1):P191CrossRefPubMedCentral

Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G et al (2014) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res 66(1):104–112. https://doi.org/10.1002/acr.22181 CrossRef

Mavrogeni S, Karabela G, Stavropoulos E, Gialafos E, Sfendouraki E et al (2013) Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. Int J Cardiol 168(4):4333–4335. https://doi.org/10.1016/j.ijcard.2013.05.085 CrossRefPubMed

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8(5):526–536. https://doi.org/10.1016/j.jcmg.2014.12.025 CrossRefPubMed

Giles JT, Malayeri AA, Fernandes V, Post W, Blumenthal RS et al (2010) Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum 62(4):940–951CrossRefPubMedPubMedCentral

10.

Erhayiem B, McDiarmid A, Swoboda P, Kidambi A, Ripley D et al (2015) OP0163 treatment-naïve, early rheumatoid arthritis Patients demonstrate vascular and myocardial abnormalities on cardiac MRI. Ann Rheum Dis 74(Suppl 2):130–131. https://doi.org/10.1136/annrheumdis-2015-eular.5279 CrossRef

11.

Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res 65(4):534–543. https://doi.org/10.1002/acr.21861 CrossRef

12.

Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y et al (2014) Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 41(10):1916–1921. https://doi.org/10.3899/jrheum.131540 CrossRefPubMed

13.

Crowson CS, Nicola PJ, Kremers HM, O’Fallon WM, Therneau TM et al (2005) How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52(10):3039–3044. https://doi.org/10.1002/art.21349 CrossRefPubMed

14.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRefPubMed

15.

Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 38(1):38–43CrossRefPubMed

16.

Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137–145CrossRefPubMed

17.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419CrossRefPubMed

18.

Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP et al (2003) Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17(3):323–329. https://doi.org/10.1002/jmri.10262 CrossRefPubMed

19.

Burns J, Sivananthan MU, Ball SG, Mackintosh AF, Mary DASG et al (2007) Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension—response. Circulation 116(17):E417–E417. https://doi.org/10.1161/Circulationaha.107.725903 CrossRef

20.

Lee JM, Shirodaria C, Jackson CE, Robson MD, Antoniades C et al (2007) Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 4(1):44–48. https://doi.org/10.3132/dvdr.2007.005 CrossRefPubMed

21.

Messroghli DR, Bainbridge GJ, Alfakih K, Jones TR, Plein S et al (2005) Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology 235(1):229–236. https://doi.org/10.1148/radiol.2351040249 CrossRefPubMed

22.

Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26(4):1081–1086. https://doi.org/10.1002/jmri.21119 CrossRefPubMed

23.

Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU et al (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T-1 mapping of the heart. Magnet Reson Med 52(1):141–146. https://doi.org/10.1002/mm.20110 CrossRef

24.

Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15(1):35CrossRefPubMedPubMedCentral

25.

Oliver JJ, Webb DJ (2003) Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscl Throm Vas 23(4):554–566CrossRef

26.

Ibrahim ESH, Johnson KR, Miller AB, Shaffer JM, White RD (2010) Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques. J Cardiovasc Magn Reson 12(1):26CrossRefPubMedCentral

27.

Ripley DP, Negrou K, Oliver JJ, Worthy G, Struthers AD et al (2015) Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study. Clin Exp Hypertens 37(4):308–316. https://doi.org/10.3109/10641963.2014.960974 CrossRefPubMed

28.

Swoboda PP, Larghat A, Zaman A, Fairbairn TA, Motwani M et al (2014) Reproducibility of myocardial strain and left ventricular twist measured using complementary spatial modulation of magnetization. J Magn Reson Imaging 39(4):887–894. https://doi.org/10.1002/jmri.24223 CrossRefPubMed

29.

Musa TA, Uddin A, Swoboda PP, Fairbairn TA, Dobson LE et al (2017) Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality. J Cardiovasc Magn Reson 19(1):13. https://doi.org/10.1186/s12968-017-0329-7 CrossRefPubMedPubMedCentral

30.

McDiarmid AK, Broadbent DA, Higgins DM, Swoboda PP, Kidambi A et al (2015) The effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic resonance imaging. Quant Imaging Med Surg 5(4):503–510. https://doi.org/10.3978/j.issn.2223-4292.2015.04.07 CrossRefPubMedPubMedCentral

31.

Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65–70

32.

Corrao S, Argano C, Pistone G, Messina S, Calvo L et al (2015) Rheumatoid arthritis affects left ventricular mass: systematic review and meta-analysis. Eur J Intern Med 26(4):259–267. https://doi.org/10.1016/j.ejim.2015.02.008 CrossRefPubMed

33.

Midtbo H, Semb AG, Matre K, Kvien TK, Gerdts E (2017) Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. Ann Rheum Dis 76(2):371–376. https://doi.org/10.1136/annrheumdis-2016-209223 CrossRefPubMed

34.

Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21(16):1387–1396. https://doi.org/10.1053/euhj.2000.2011 CrossRefPubMed

35.

Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2(4):271–278CrossRefPubMed

36.

Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA et al (2012) LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 5(8):837–848. https://doi.org/10.1016/j.jcmg.2012.06.003 CrossRefPubMedPubMedCentral

37.

Ciftci O, Yilmaz S, Topcu S, Caliskan M, Gullu H et al (2008) Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 198(2):332–337. https://doi.org/10.1016/j.atherosclerosis.2007.11.013 CrossRefPubMed

38.

Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35(3):569–582CrossRefPubMed

39.

Myasoedova E, Davis JM 3rd, Crowson CS, Roger VL, Karon BL et al (2013) Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum 65(7):1713–1718. https://doi.org/10.1002/art.37949 CrossRefPubMedPubMedCentral

40.

Summers GD, Deighton CM, Rennie MJ, Booth AH (2008) Rheumatoid cachexia: a clinical perspective. Rheumatology 47(8):1124–1131. https://doi.org/10.1093/rheumatology/ken146 CrossRefPubMed

41.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C et al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381. https://doi.org/10.1093/eurheartj/ehw106 CrossRefPubMedPubMedCentral

42.

Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF et al (2015) Trial of atorvastatin for the primary prevention of cardiovascular events in patients with RA (TRACE RA): a randomized trial in 2986 RA patients (094). Rheumatology 54(suppl 1):i87. https://doi.org/10.1093/rheumatology/kev088.094 CrossRef

43.

Scott IC, Ibrahim F, Johnson D, Scott DL, Kingsley GH (2012) Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 30(2):228–232PubMed

Title: Cardiovascular MRI evidence of reduced systolic function and reduced LV mass in rheumatoid arthritis: impact of disease phenotype
Authors: L. A. Bissell
B. Erhayiem
E. M. A. Hensor
G. Fent
A. Burska
A. K. McDiarmid
P. P. Swoboda
H. Donica
S. Plein
M. H. Buch
J. P. Greenwood
J. Andrews
Publication date: 01-03-2020
Publisher: Springer Netherlands
Keyword: Rheumatoid Arthritis
Published in: The International Journal of Cardiovascular Imaging / Issue 3/2020
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-019-01714-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardiovascular MRI evidence of reduced systolic function and reduced LV mass in rheumatoid arthritis: impact of disease phenotype

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

Comparison of quantitative flow ratio and fractional flow reserve with myocardial perfusion scintigraphy and cardiovascular magnetic resonance as reference standard. A Dan-NICAD substudy

Verification of threshold for image intensity ratio analyses of late gadolinium enhancement magnetic resonance imaging of left atrial fibrosis in 1.5T scans

Contrast-enhanced echocardiographic measurement of longitudinal strain: accuracy and its relationship with image quality

Impact of baseline calibration on semiquantitative assessment of myocardial perfusion reserve by adenosine stress MRI

Global myocardial longitudinal strain in a general population—associations with blood pressure and subclinical heart failure: The Tromsø Study

Stroke volume and cardiac output measurement in cardiac patients during a rehabilitation program: comparison between tonometry, impedancemetry and echocardiography